AVACEN is helping to solve this problem without the use of drugs or other invasive treatments.
AVACEN recently launched its 3rd-generation family of unique consumer and practitioner products.
The AVACEN team is backed by successful leaders who have helped the company secure 17 patents.
AVACEN has completed 10 pilot studies all supporting billion-dollar market opportunities such as chronic pain and opiod addiction.
